Deutsche Börse

(IN BRIEF) Eckert & Ziegler Radiopharma GmbH has entered into a clinical manufacturing agreement with Pentixapharm AG to supply GMP-grade Y90-PentixaTher doses for use in ongoing trials. The radiolabeled therapy targets cancers overexpressing the CXCR4 receptor and supports a theranostic … Read the full press release →

(IN BRIEF) Vonovia SE will propose Michael Rüdiger and Dr Marcus Schenck for election to its Supervisory Board at the 2025 Annual General Meeting, replacing Dr Ute Geipel-Faber and Hildegard Müller. Both nominees bring decades of leadership in the financial … Read the full press release →

(IN BRIEF) Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. have announced a significant global supply agreement aimed at supporting AtomVie’s radiopharmaceutical manufacturing efforts. Under this agreement, Eckert & Ziegler will provide its high-grade non-carrier added Lutetium-177 chloride (Theralugand®) … Read the full press release →

(IN BRIEF) The venture capital landscape is evolving as priorities shift, with climate technology losing some of its earlier momentum while sectors like cybersecurity, artificial intelligence, and defense see increased investment interest. Young businesses focused on these areas are expected … Read the full press release →

(IN BRIEF) A new report from Market Structure Partners (MSP) reveals that European stock exchanges are increasingly relying on market data sales to offset declining trading revenues, resulting in rising costs for equity market data. Despite reduced trading volumes, exchanges … Read the full press release →